Spectrum Pharmaceuticals

Results: 23



#Item
1Microsoft Word - FINAL 10K2014-Cover Page final to print

Microsoft Word - FINAL 10K2014-Cover Page final to print

Add to Reading List

Source URL: www.casipharmaceuticals.com

Language: English - Date: 2015-04-17 14:04:48
2MARKET SNAPSHOT Stock priceweek range Market capitalization Shares outstanding Institutional ownership

MARKET SNAPSHOT Stock priceweek range Market capitalization Shares outstanding Institutional ownership

Add to Reading List

Source URL: www.casipharmaceuticals.com

Language: English - Date: 2016-06-03 11:22:57
3Sunovion Pharmaceuticals Inc. 84 Waterford Drive, Marlborough, MATelNews Release Contact:

Sunovion Pharmaceuticals Inc. 84 Waterford Drive, Marlborough, MATelNews Release Contact:

Add to Reading List

Source URL: www.sunovion.com

Language: English - Date: 2015-05-19 10:54:48
4IPandYou_Bulletin_Antibiotics resistance

IPandYou_Bulletin_Antibiotics resistance

Add to Reading List

Source URL: apic.org

Language: English - Date: 2014-04-23 15:02:49
5IPandYou_Bulletin_Antibiotics resistance

IPandYou_Bulletin_Antibiotics resistance

Add to Reading List

Source URL: www.apic.org

Language: English - Date: 2014-04-23 15:02:49
6Annex 2. University of Galway reporton toolkit materials

Annex 2. University of Galway reporton toolkit materials

Add to Reading List

Source URL: www.ecdc.europa.eu

Language: English - Date: 2014-09-18 08:28:01
7Broad Spectrum Antimicrobials (BSA) Program

Broad Spectrum Antimicrobials (BSA) Program

Add to Reading List

Source URL: www.medicalcountermeasures.gov

Language: English - Date: 2014-11-14 13:43:04
8Judicious Use of Antimicobials for Poultry Producers

Judicious Use of Antimicobials for Poultry Producers

Add to Reading List

Source URL: www.fda.gov

Language: English
9Antibiotic Stewardship Driver Diagram and Change Package

Antibiotic Stewardship Driver Diagram and Change Package

Add to Reading List

Source URL: www.cdc.gov

Language: English - Date: 2012-11-07 11:10:54
10Acknowledgement and Consent for Disclosure of Potential Conflict(s) of Interest and Waivers under 18 U.S.C. §208(b)(3) and 21 U.S.C. $355 (n)(4) Otis Brawley, M.D. Commi.ttee:

Acknowledgement and Consent for Disclosure of Potential Conflict(s) of Interest and Waivers under 18 U.S.C. §208(b)(3) and 21 U.S.C. $355 (n)(4) Otis Brawley, M.D. Commi.ttee:

Add to Reading List

Source URL: www.fda.gov

Language: English - Date: 2007-07-09 08:23:18